Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Cardiac arrest; pulmonary embolism; This is a spontaneous report downloaded from the regulatory authority. The Regulatory authority report number is DE-PEI-CADR2021015340. A non-contactable consumer reported that an 82-years-old male patient received BNT162B2 (COMIRNATY, Solution for injection, Lot number and Expiry dates were not reported), via intramuscular route of administration, on 23Jan2021, as single dose for COVID-19 immunisation. Medical history included shoulder operation NOS in Nov2020 (2 shoulder surgeries in November 2020), ongoing parkinson''s disease, ongoing Bechterew''s disease and ankylosing spondylitis. The patient''s concomitant medications were not reported. On 23Jan2021 patient experienced cardiac arrest, pulmonary embolism. The outcome of the cardiac arrest was fatal and for pulmonary embolism outcome was unknown. The patient died on an unspecified date in 2021 due to cardiac arrest. It was not reported if an autopsy was performed. Causality: Inconsistent causal association to immunization for both events. Sender Comment: Parkinson''s disease, ankylosing spondylitis, 2 shoulder surgeries in November 2020/ cardiac arrest diagnosis pulmonary embolism Follow-up activities closed: downloaded from database.; Reported Cause(s) of Death: Cardiac arrest
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166